Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Monitoring
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Alcohol and drug treatment
Digital technology - benefits and risks
Alcohol — Monitoring
E-health — Monitoring
Infectious diseases — Monitoring
Markets — Monitoring
Monitoring — New trends
Monitoring — Treatment: medical/pharmacological
Opiates — Monitoring
10:50
High-risk drug use and health threats in Eastern Europe
Focus on the EU borders
10:50
to
12:20
Central square 3 (C3)
Katri Abel-Ollo
Anne Bergenström
Innovative methods for exploring new drug-related trends
10:50
to
12:20
Insights zone 4 (I4)
João Matias
Stimulants — use, harm and interventions
10:50
to
12:20
Networking zone 4 (N4)
Janusz Sieroslawski
Definition of disorders
10:50
to
12:20
Networking zone 1 (N1)
Viktor Mravčík
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
Understanding behaviours, risks and harms
10:50
to
12:20
Networking zone 3 (N3)
Xavier Majó
Monitoring trends and developments
10:50
to
12:20
Insights zone 1 (I1)
Larissa Maier
12:20
Measuring drug use to monitor trends in different populations - ISSDP poster session 1
12:20
to
13:20
Guided poster tours room
Nicola Singleton
Making better use of existing data through standardisation, methods and analysis - ISSDP poster session 2
12:20
to
13:20
Guided poster tours room
Rosalie Pacula
13:20
The challenges of monitoring new drugs
13:20
to
14:50
Insights zone 2 (I2)
Ana Gallegos
Addicted to work: the use of cognitive enhancers in the workplace and the implications for occupational safety and health
13:20
to
14:50
Futures zone 2 (F2)
William Cockburn
Opioid-related deaths: learning from pharmacology, laboratory-based studies and physical assessments
13:20
to
14:50
Central square 1 (C1)
Sir John Strang
Reducing drug-related deaths
13:20
to
14:50
Central square 2 (C2)
Catherine Comiskey
Treatment adherence
13:20
to
14:50
Insights zone 4 (I4)
Marta Torrens Melich
Using new technology and innovative methods to measure substance use and related harm
13:20
to
14:50
Networking zone 1 (N1)
Peter Reuter
The Reitox network poster session
13:20
to
14:50
Guided poster tours room
Nadine Berndt
16:50
Towards a public health approach
An epidemiological overview of new psychoactive substances use in Europe
16:50
to
18:20
Central square 3 (C3)
Margriet van Laar
Developing tools for monitoring of drug policy and practice from the view point of civil society organisations in Europe
16:50
to
18:20
Insights zone 1 (I1)
Eberhard Schatz
Emerging drug trends in North Africa and Middle East
Focus on the EU borders
16:50
to
18:20
Insights zone 2 (I2)
Ioanna Yiasemi
Thomas Néfau
Factors influencing recovery
16:50
to
18:20
Insights zone 3 (I3)
Eilish Gilvarry
Methods and measurement of economic cost of substance use
16:50
to
18:20
Central square 3 (C3)
Rosalie Pacula
New methods
16:50
to
18:20
Central square 2 (C2)
André Noor
18:30
Innovative approaches for assessing or impacting demand for substances
18:30
to
19:30
Central square 1 (C1)
Anne Line Bretteville-Jensen
Lessons from the field
Measuring and monitoring drug policy for research, surveillance and practice
18:30
to
19:30
Networking zone 1 (N1)
Rosalie Pacula
Software-automated approach to monitoring online e-shops offering new psychoactive substances
18:30
to
19:30
Futures zone 3 (F3)
Vendula Belackova
Martin Pazitny
Opioids — current and emerging lessons
18:30
to
19:30
Networking zone 4 (N4)
Roumen Sedefov
Nightlife, festivals and other recreational settings
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Prevention science and measurement of demand reduction quality standards
18:30
to
19:30
Central square 1 (C1)
Nicola Singleton
15:00
Methodological challenges and comparative analyses in five European countries
Insight into the dynamics of substance use (research) in nightlife settings
15:00
to
16:30
Networking zone 1 (N1)
João Matias
Drug markets
15:00
to
16:30
Insights zone 4 (I4)
Dirk Korf
Opioid-related deaths and other harms: current and emerging lessons - SSA poster session
15:00
to
16:30
Guided poster tours room
Sarah Welch
10:45
online registration required
Supporting future cannabis policy/achieving a Standard Joint Unit – FuturiZe workshop
10:45
to
12:15
Futures zone 3 (F3)
Antoni Gual
Hugo López-Pelayo
Drug policy debates: how are routine monitoring data used?
10:45
to
12:15
Insights zone 2 (I2)
Lies Gremeaux
Diversity in behavioural addictions
10:45
to
12:15
Networking zone 1 (N1)
Fernando Fernandez-Aranda
Therapeutic horizons II
10:45
to
12:15
Central square 1 (C1)
Felix Carvalho
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
10:55
Oral presentation
Dynamics in emerging drug use prevalence among people who inject drugs in Ukraine between 2013 and 2017
10:55
to
11:10
Central square 3 (C3)
Slava Kushakov
11:00
Short communication
Do more people in Europe need treatment for problems related to cocaine use? An analysis of cocaine treatment demand in nine European countries
11:00
to
11:10
Networking zone 4 (N4)
Antoine Jérôme
Oral presentation
Lessons learned from 25 years of drug checking in the Netherlands
11:00
to
11:15
Insights zone 4 (I4)
Laura Smit-Rigter
Oral presentation
Views about the disease and brain disease model of addiction: an international survey of addiction treatment providers in the USA, UK and Australia
11:00
to
11:15
Networking zone 1 (N1)
Anthony Barnett
11:10
Short communication
Psychostimulant induce neuronal plasticity by cytoskeleton remodeling via cdc42 pathway
11:10
to
11:20
Networking zone 4 (N4)
Andrea Lobo
Oral presentation
Patterns of NPS consumption and perceived risks and benefits: results of online survey in Georgia
11:10
to
11:25
Central square 3 (C3)
David Otiashvili
11:15
Oral presentation
Harm reduction agencies and monitoring the responses to drug-related harm
11:15
to
11:30
Insights zone 4 (I4)
Tuukka Tammi
Oral presentation
Reconsidering cannabis dependence
11:15
to
11:30
Networking zone 1 (N1)
Liz Temple
11:25
Oral presentation
Research on the use of new psychoactive substances and challenges in responding to it in Moldova (Eastern Europe)
11:25
to
11:40
Central square 3 (C3)
Eliza Kurcevic
11:30
Oral presentation
Monitoring drug use through wastewater analysis in Spain
11:30
to
11:45
Insights zone 4 (I4)
José Benito Quintana
Oral presentation
Agreement degree with the content of the Substance Addiction Consequences Scale items - The development of a new instrument.
11:30
to
11:45
Networking zone 1 (N1)
Paulo Seabra
11:40
Short communication
Crackland in Brazil: epidemiological monitoring method and results
11:40
to
11:50
Networking zone 4 (N4)
Clarice Madruga
Oral presentation
Drug use, HIV, HCV, including in prisons, in Eastern Europe: trends and implications for policy and programmes
11:40
to
11:55
Central square 3 (C3)
Lyuba Azbel
11:45
Oral presentation
ESCAPE (European Syringe Collection & Analysis Project Enterprise): a multi-city study of monitoring consumption trends of people who inject drugs
11:45
to
12:00
Insights zone 4 (I4)
Thomas Néfau
Oral presentation
Characterising people that demanded drug treatment in Catalonia: a cluster analysis
11:45
to
12:00
Networking zone 1 (N1)
Xavier Majó
11:50
Short communication
'I have no clue why I’m doing this' – a qualitative study on crack cocaine use in Frankfurt, Germany
11:50
to
12:00
Networking zone 4 (N4)
Bernd Werse
12:20
Poster
Illegal drug trends in Taiwan, 2009-2018
12:20
to
13:20
Guided poster tours room
Kai-Hsiang Kang
Poster
Gender convergence in alcohol consumption: outcomes from general population survey on drugs, Portugal 2001-2016/17
12:20
to
13:20
Guided poster tours room
Clara Vital
Poster
Monitoring recreational drug use in Switzerland
12:20
to
13:20
Guided poster tours room
Dominique Schori
Poster
Prevalence and patterns of drug use indicator (‘GPS’)
12:20
to
13:20
Guided poster tours room
Federica Mathis
Poster
European web survey on drugs: patterns of use
12:20
to
13:20
Guided poster tours room
João Matias
13:30
Oral presentation
The advantages and challenges of developing a national earlier warning system - Transforming Bergen Earlier Warning System (BEWS) into Norwegian National Earlier Warning System (NNEWS).
13:30
to
13:45
Insights zone 2 (I2)
Else Kristin Utne Berg
13:45
Oral presentation
New psychoactive substances in Portugal
13:45
to
14:00
Insights zone 2 (I2)
Ludmila Carapinha
14:00
Oral presentation
Recent use of synthetic cannabinoids, synthetic opioids and other psychoactive drug groups among high-risk drug users in Israel.
14:00
to
14:15
Insights zone 2 (I2)
Barak Shapira
14:15
Oral presentation
Use of physiologically based pharmacokinetic modelling of new psychoactive substances
14:15
to
14:30
Insights zone 2 (I2)
Nuno Elvas Silva
14:30
Oral presentation
Combining monitoring data to evaluate responses to NPS: the case of 4-FA in the Netherlands
14:30
to
14:45
Insights zone 2 (I2)
Margriet van Laar
16:50
Description of the contents of the workshop
16:50
to
17:00
Insights zone 1 (I1)
Eberhard Schatz
Oral presentation
Prevalence and patterns of NPS use in general and school European populations
16:50
to
18:20
Central square 3 (C3)
Julian Vicente
Oral presentation
NPS use in self-selected respondents of the population (EU web-survey)
16:50
to
18:20
Central square 3 (C3)
Julian Vicente
Oral presentation
Assessing patterns of use of new psychoactive substances (NPS) – the NPS Euronet project
16:50
to
18:20
Central square 3 (C3)
Noelia Salgueiro-González
Oral presentation
Drug trends at UK festivals and self-reported information and treatment needs by people who use NPS
16:50
to
18:20
Central square 3 (C3)
Katy MacLeod